ISSN:
Journal Home
Journal Guideline
Molecular Cancer Therapeutics Q1 Unclaimed
American Association for Cancer Research Inc.
United States
Molecular Cancer Therapeutics is a journal indexed in SJR in Oncology and Cancer Research with an H index of 182. It has a price of 3000 €. It has an SJR impact factor of 1.831 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1.831.
Molecular Cancer Therapeutics focuses its scope in these topics and keywords: inhibitor, cancer, potent, cells, protein, resistance, activity, receptor, inhibition, vitro, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -


Categories:
Cancer Research (Q1)
Oncology (Q1)
Price
3000 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1.831
SJR Impact factor182
H Index239
Total Docs (Last Year)715
Total Docs (3 years)11189
Total Refs4526
Total Cites (3 years)706
Citable Docs (3 years)5.53
Cites/Doc (2 years)46.82
Ref/DocOther journals with similar parameters
Cancer Cell Q1
Journal of Clinical Oncology Q1
Annals of Oncology Q1
Molecular Cancer Q1
Cancer Discovery Q1
Compare this journals
Comments